Abpro (ABP) Short Interest Ratio & Short Volume

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.92% of Abpro's floating shares are currently sold short.

Abpro saw a increase in short interest in February. As of February 13th, there was short interest totaling 44,926 shares, an increase of 146.1% from the previous total of 18,253 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.92% of Abpro's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Abpro: Aptevo Therapeutics Inc. (7.81%), Flora Growth Corp. (2.22%), Cyclacel Pharmaceuticals, Inc. (1.36%), Cuprina Holdings (Cayman) LTD (0.45%), Entero Therapeutics, Inc. (0.86%), Cardio Diagnostics Holdings, Inc. (1.82%), Psyence Biomedical Ltd. (4.23%), Redhill Biopharma Ltd. (0.39%), Aptorum Group Limited (0.88%), Purple Biotech Ltd. Sponsored ADR (0.84%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.25 billion), Invesco QQQ ($31.19 billion), iShares Russell 2000 ETF ($20.38 billion), iShares 20+ Year Treasury Bond ETF ($12.16 billion), SPDR S&P Biotech ETF ($9.44 billion), Western Digital Corporation ($8.89 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.13 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.79 billion), Lumentum Holdings Inc. ($6.07 billion), and Carvana Co. ($5.21 billion). View all of the most shorted stocks.

Short selling ABP is an investing strategy that aims to generate trading profit from Abpro as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Abpro occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABP, twice per month. The most recent reporting period available is February, 13 2026.